People

  1. Mychalczak
    Mychalczak
  2. Jones
    Jones
  3. Rousseau
    Rousseau
  4. Barin
    Barin
  5. Sokolowski
    Sokolowski
  6. Bao
    Bao
  7. Lin
    Lin
  8. Dantuluri
    Dantuluri
  9. Iyer
    Iyer
  10. Koo
    Koo
  11. Kantor
    Kantor
  12. Kabel
    Kabel
  13. Kuo
    Kuo
  14. Mcpherson
    Mcpherson
  15. Leitao
    Leitao

Recent Works

  1. Brentuximab vedotin with chemotherapy for patients with previously untreated stage III/IV classical Hodgkin lymphoma: 5-year update of the ECHELON-1 study
    Meeting Abstract

    Ramchandren, R.; Długosz-Danecka, M.; Connors, J. M.; Radford, J.; Illés, A.; Picardi, M.; Lech-Maranda, E.; Feldman, T.; Smolewski, P.; Savage, K. J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  2. The BET inhibitor pelabresib decreases inflammatory cytokines, improves bone marrow fibrosis and function, and demonstrates clinical response irrespective of mutation status in myelofibrosis patients in the phase 2 MANIFEST trial
    Meeting Abstract

    Zavidij, O.; Keller, P.; Cui, J. K.; Mertz, J.; Salama, M.; Olteanu, H.; Chiu, A.; Chen, D.; Hanson, C. A.; Chen, Z. H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  3. Pelabresib (CPI-0610) improved anemia associated with myelofibrosis: Interim results from the ongoing MANIFEST phase 2 study
    Meeting Abstract

    Bose, P.; Verstovsek, S.; Kremyanskaya, M.; Mascarenhas, J.; Talpaz, M.; Harrison, C.; Rampal, R.; Patriarca, A.; Gupta, V.; Granacher, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save